• Infectious Diseases


    As the official educational partner for the University of Nebraska Medical Center (UNMC) Center for Continuing Education (CCE) and the Mycoses Study Group Education & Research Consortium (MSG-ERC), Terranova Medica has been successful in developing educational offerings since 2010. Terranova has recently developed “The New Antifungal Toolkit 2017: The Pharmacopeia and Beyond” with MSG and UNMC. This internet CME curriculum provides current information about newer FDA-approved agents/formulations for the management of invasive fungal infections and evaluates their role in strategies to optimize antifungal therapy. Visit to see our latest activities.

    Terranova is also collaborating on educational efforts to address sexual health, HIV risk, and HIV prevention in the primary care setting. In April 2017, our collaboration delivered a live meeting at the Colorado Academy of Family Physicians (CAFP) Summit on these topics, following by enduring activities with regionally customized content for use across the state of Colorado. We also created a CME activity to appear in the Winter 2018 issue of Colorado Family Physician. And through our collaboration with the Colorado Health Network, the CAFP, and Postgraduate Institute for Medicine, we are addressing patient support services and links to care in this grass-roots effort. Visit to learn more.


    Lisa Tushla, PhD, H(ASCP), completed her doctoral work and postdoctoral work focusing on important topics in infectious diseases—from the role of the neutrophil in mediating the response to endotoxemia to the role of defensins in mediating colonization vs infection of leg ulcer fluids. Subsequently, Lisa worked on various infectious disease projects in the areas of otitis media, intra-abdominal infections, skin surface infections, and fungal infections. Her special interest in fungal infections can be attributed to her long-standing collaborations with the MSG since 2005, when she helped launch the Front-Line Fungus project with Peter Pappas, MD.


    The Colorado Health Network is excited to provide our patients with referrals to medical providers who are knowledgeable about HIV prevention and care. We have the tools to help your patients access and pay for prevention medications that work in stopping the spread of HIV. Please visit to find out more about how we can work together to end this epidemic.

     Jessica Kobylinski
    Program Quality Officer, Colorado Health Network, Inc.

    I am so pleased with the strides the MSGERC has made recently. With the establishment of the MSGERC as a non-profit organization, the development of the first exclusive MSG website (, and our continued success in education programming, we are gaining significant momentum as an organization. We are also pleased to see great attendance at our international CME events as well as increased traffic to our dedicated CME site, I look forward to the continued expansion of our educational efforts in terms of innovative educational designs, increased audience reach, and high–level outcomes evaluations. I thank Carolynn Thomas Jones, DNP, MSPH, RN, for her invaluable help in getting the non-profit established and working; Dr Lisa Tushla and Mr. Tom Davis at Terranova; Lois Colburn at UNMC CCE for all of their efforts in moving this educational collaboration forward; and the Education Committee of the MSGERC, particularly Chairs Drs. John Baddley and G.R. Thompson, for their leadership in fungal education. We also thank our commercial supporters, who have provided the continued financial support that makes all this wonderful programming possible.

    Peter G. Pappas, MD
    Director, Mycoses Study Group

  • Melanoma


    One of our proudest accomplishments in our long-standing collaboration with AIM at Melanoma is the establishment of the Melanoma Nursing Initiative (MNI), a comprehensive resource about immunotherapies and targeted therapies created for oncology nurses and advance practice providers to assist them in providing optimal outcomes for their patients with melanoma. The initiative was developed to meet several goals—the most pressing being the need to improve the early recognition and management of the side effects associated with newer melanoma therapies, particularly in the community setting. The initiative’s website,, serves as a 1-stop shop for all MNI materials. It houses the MNI consensus statements (featuring care step pathways) as published in a recent 7-article supplement to the Clinical Journal of Oncology Nursing (CJON).

    The MNI site also contains comprehensive nurse toolkits on newer melanoma therapies for use in the in-practice setting as well as customizable companion patient resources, with key information on dosing, administration, side effects, and educational and financial resources. The side-effect search functionality enables healthcare providers to search for side-effect management strategies via text-based searches supporting both telephone triage and in-office assessments.  News feeds also help the learner keep up with the recent advances in melanoma management. Finally, the Q/A portal provides an expert-led discussion board for real-time exchange among professionals regarding day-to-day issues encountered in the clinic. The content is available for both online viewing and download/print across a range of devices.

    We are currently taking the same “Initiative” approach with a pan-tumor project.


    Lisa A. Tushla, PhD, H(ASCP), has a deep history in melanoma. In her postdoctoral work at the University of Pennsylvania, she worked in collaboration with her late husband, dermatologist William P. Carey, Jr, MD, and Tom Kieber-Emmons, PhD, on melanoma clinical and animal models. With the launch of PharmAdura, LLC in 2003 (now Paradigm Medical Communications), Lisa drew on her relationships and knowledge in the field to help secure the Melanoma Care Coalition project, still ongoing at Paradigm, which also helped her attain a 2007 Alliance for CME Award for outstanding collaboration. In recent years, Lisa has dived back deep in the field of melanoma and is looking forward to expanding the collaborations to the CME arena.


    I have been working with Terranova on melanoma projects for several years. Put simply, they “get it”– whether it’s the science, the clinical gap, or the unmet educational need for patients and clinicians. Beyond that, they have long-term and strong relationships with many of their melanoma experts, which means their collaborations go smoothly and productively.

    Today, we are seeing a large shift in the management of melanoma—more than 80% of patients are being treated in the community setting, by clinical teams who manage a variety of tumors and may see relatively few melanoma cases. Added to that is the challenge of identifying and treating the side effects of the newer melanoma therapies, many of which are unique, immune-mediated, and very different from those seen with chemotherapy. As a result, there is a huge unmet educational need for clear, concise, and easy-to-access education for these busy community-based professionals.

    I look forward to continuing to work with Terranova on future medical education and patient education projects!

    Valerie Guild, MBA, MS
    President, AIM at Melanoma Foundation

    The emergence of immunotherapy (specifically the checkpoint inhibitors) as a mainstay treatment for advanced melanoma highlights the importance of nursing involvement in the care of patients on these therapies. Never before has the field witnessed such a rapidly evolving and dramatic paradigm shift in the availability of effective therapies for so many patients. While oncology nurses are thought of as experts in these areas, the toxicity associated with checkpoint inhibitors and the associated management strategies vastly differ from traditional chemotherapy.  The MNI faculty have a wealth of experience using these regimens and are in the best position to provide the expert guidance on their optimal use. That is the idea of the initiative—to empower our nursing colleagues in the community with the necessary information and tools to provide the best care possible for patients receiving immunotherapy.

    Krista Rubin, MS, FNP-BC
    Nurse Practitioner, Center for Melanoma, Massachusetts General Hospital Cancer Center

  • Multiple Sclerosis


    Terranova is a founding member of the MS Educational Alliance, a collaborative medical education partnership that has delivered several MS related activities in recent years. Members of the Terranova team have been involved with the following MS activities:

    • Timing is Everything: The Importance of Early Intervention in Multiple Sclerosis (QuestMedEd e-based Curriculum, 2008)
    • Sound Strategies for Multiple Sclerosis: The Longer-Term Perspective (QuestMedEd e-based Curriculum, 2009)
    • MS Management: The Immunosuppressive Debate (MS Educational Alliance, Enduring debate and case-based activity with DVD,  2010)
    • Troubles and Triumphs in MS Diagnosis (MS Educational Alliance, video/DVD online, 2010)
    • When Your MS Patient Gets Sick (MS Educational Alliance, DVD/Enduring activity, 2011)
    • Lessons Learned from Challenging Cases (MS Educational Alliance, Enduring case-based activity, 2013, ongoing) Available at

    In addition, Terranova staff have worked with the ACHS on several MS related activities.


    Terranova Medica, LLC staff members have been active in many areas of neurology continuing education, including Alzheimer’s disease, cognitive aging, cervical dystonia, narcolepsy, sleep, and particularly, MS. UNMC CCE works closely with the course chair, Lisa A. Tushla, PhD, H(ASCP), of Terranova, a biomedical scientist who has been working on neurology educational initiatives for over 15 years. Terranova’s program director, Tom Davis, has expertise in the program management and development of MS education for over 5 years. Terranova has worked with an experienced medical writer who has extensive training in neurology.